Publications

To win the techno-economic competition with China, America must be able to assess the factors impacting the global competitiveness of its advanced-technology industries. Using the auto industry as a template, U.S. competitiveness has faltered considerably.

A report estimates that in the 149 American counties that had semiconductor activity prior to the passage of the U.S. Innovation and Competitiveness Act (USICA), the precursor bill to the CHIPS Act, employment increased by 110 jobs per county, equivalent to a 12.7 percent increase in employment.

The Commission should resolve Kuiper Systems' application consistently with the policy vision embodied in its reforms to the satellite milestone and bond system as proposed in the Space Modernization Proceeding.

Policymakers who want to protect patients while ensuring clinicians can use tools that improve care should look to Utah for how regulatory sandboxes can maximize patient access to beneficial tools while minimizing clinical risk.

As Korea’s labor debate moves into digital policy, unions risk harming workers in the next generation of industries by prioritizing protections for existing jobs over preparing workers for technological transition.

A poll built on leading questions, false choices, and fearmongering does not reflect actual public opinion on AI. It shows how to optimize disinformation for partisan messaging.

CFIUS’ procedures need to be strengthened to ensure that Chinese entities, particularly those influenced or backed by Chinese government influence or funding, cannot acquire U.S. companies or technology that could harm America’s economic or national security.

Korea is trying to unlock high quality data for AI competitiveness, but its push for strict domestic data storage risks isolating developers from the global infrastructure and partnerships modern AI depends on. A more effective approach would protect sensitive data through targeted safeguards rather than blunt geographic restrictions that ultimately undermine innovation and market competition.

Europe once led the world in biopharmaceutical innovation, but it lost ground after adopting policies that weakened incentives for R&D and innovation. America must learn from Europe’s experience to preserve its own biopharma leadership and the related economic benefits and access to the most innovative drugs.

Joseph V. Coniglio hosts the third episode of a new antitrust speaker series and interviews longtime antitrust scholar and retired DOJ economist Greg Werden.​ They discuss Werden’s path from chemistry to economics and his four-decade career at DOJ, discussing both constants and changes in antitrust enforcement.